MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Smell as a Diagnostic Signature: Systematic Review and Meta-Analysis of UPSIT Accuracy in Distinguishing Parkinson’s Disease from Essential Tremor

    M. Schiess, J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the diagnostic performance of the University of Pennsylvania Smell Identification Test (UPSIT) in differentiating Parkinson’s disease (PD) from essential tremor (ET) using…
  • 2026 International Congress

    Effects of Modafinil on Motor and Non‑Motor Outcomes in Parkinson’s Disease: A Meta‑Analysis of Randomized, Placebo‑Controlled Trials

    A. Lin, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Cincinnati, USA)

    Objective: To determine the efficacy and safety of modafinil on motor and non-motor outcomes in Parkinson’s disease (PD) using evidence exclusively from randomized placebo‑controlled clinical…
  • 2026 International Congress

    Smell Testing in The Global Parkinson’s Genetics Program (GP2)

    S. Meyer, L. Jones, S. Waters, E. Navarro-Jones, M. Tan, K. Atterling-Brolin, L. Lange, M. Teresa Periñan, J. Trinh, C. Gabbert, A. Noyce, G. Genetics Program (London, United Kingdom)

    Objective: To identify cohorts with existing olfactory data within the Global Parkinson’s Genetics Program (GP2, http://gp2.org/). To support harmonisation across cohorts and facilitate future expansion…
  • 2026 International Congress

    Why Context Matters: The Influence of Medication and Environment on Real-World Gait in People with Parkinson’s Disease

    C. Lang, M. Galeon, C. Kirk, E. Packer, N. Ireson, V. Lanfranchi, L. Alcock, L. Rochester, A. Yarnall, S. Del Din*, D. Ravi* (Zurich, Switzerland)

    Objective: To quantify the extent to which contextual factors explain the variability in real-world gait outcomes in people with Parkinson’s disease (PwP) using machine learning…
  • 2026 International Congress

    High-Intensity Multimodal Training Through Group-Based Weighted Dance for Parkinson’s Disease: A Feasibility Study

    Y. Chen, S. Lai, C. Xu, K. Liu, L. Lo, T. Cheng, C. Li, C. Lui, Y. Wang, J. Jiang, Y. Wang, M. Huang (Kowloon, Hong Kong)

    Objective: To examine the feasibility and preliminary effects of a 4-week high-intensity multimodal training (HIMT) program [1], delivered through group-based weighted dance, for people with…
  • 2026 International Congress

    Real-World Clinical Outcomes of Adaptive versus Continuous Deep Brain Stimulation in Early-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis of 2024-2025 Trials

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the comparative efficacy, safety, and energy efficiency of adaptive deep brain stimulation (aDBS) versus continuous deep brain stimulation (cDBS) in Parkinson’s disease…
  • 2026 International Congress

    Classification of Fallers in Parkinson’s Disease Through Machine Learning Based Feature Analysis

    SM. Kim, MK. Kim, MJ. Chung, JW. Cho, HJ. Yoo, JY. Youn (Seoul, Republic of Korea)

    Objective: To develop and validate a machine learning model integrating clinical and gait data to identify key clinical markers associated with faller status in Parkinson’s…
  • 2026 International Congress

    Menstrual Cycle Influence on Parkinson’s Disease Symptoms in Women with Early-Onset

    E. Bagdasarova, D. Larina, I. Zdorovec, A. Shekhvatova, K. Nazarova, M. Nikolaeva, I. Miliukhina, A. Murtazina, E. Bril, O. Turgunkhujaev (Moscow, Russian Federation)

    Objective: To characterize the prevalence of menstrual cycle–related symptom fluctuations in women with early-onset Parkinson's disease (EOPD). Background: Hormonal fluctuations during the menstrual cycle may…
  • 2026 International Congress

    Exploring a Milestone-Based Approach as an Outcome Measure for Disease-Modifying Parkinson Disease Trials

    C. Gonzalez-Robles, M. Burnell, A. Schrag, R. Weil, G. Mills, ML. Zeissler, J. Carpenter, S. Gandhi, C. Carroll, T. Foltynie (London, United Kingdom)

    Objective: To replicate a composite milestone(CM) approach in a range of Parkinson Disease(PD) studies(observational, clinical trials) over a long time period(up to 12 years). To…
  • 2026 International Congress

    The Clinical and Biological effects of a Whole Foods and Plant-Based Dietary Intervention in Parkinson’s Disease

    B. Boon, S. Meles, B. Bloem, T. van Laar, E. Postma (Groningen, Netherlands)

    Objective: The Plants for Parkinson trial aims to investigate whether prolonged adherence to a plant-based and whole foods-derived dietary pattern can alleviate motor- and gastrointestinal…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley